221 related articles for article (PubMed ID: 19290852)
1. Coagulation and fibrinolysis related cytokine imbalance in preeclampsia: the role of placental trophoblasts.
Teng YC; Lin QD; Lin JH; Ding CW; Zuo Y
J Perinat Med; 2009; 37(4):343-8. PubMed ID: 19290852
[TBL] [Abstract][Full Text] [Related]
2. Abnormal expression of type 1 plasminogen activator inhibitor and tissue factor in severe preeclampsia.
Estellés A; Gilabert J; Grancha S; Yamamoto K; Thinnes T; España F; Aznar J; Loskutoff DJ
Thromb Haemost; 1998 Mar; 79(3):500-8. PubMed ID: 9580327
[TBL] [Abstract][Full Text] [Related]
3. Modulation of procoagulant and fibrinolytic system components of mesothelial cells by inflammatory mediators.
Sitter T; Toet K; Fricke H; Schiffl H; Held E; Kooistra T
Am J Physiol; 1996 Nov; 271(5 Pt 2):R1256-63. PubMed ID: 8945961
[TBL] [Abstract][Full Text] [Related]
4. Quantitative evaluation of the influence of ovarian steroids on plasminogen activators and inhibitors in human endometrial cells and trophoblasts.
Ueyama M; Kasatori N; Urayama T; Maemura T; Yao Y; Shiraishi T; Saito S; Kubo H
Thromb Res; 2002 Nov; 108(4):235-44. PubMed ID: 12617987
[TBL] [Abstract][Full Text] [Related]
5. Fibrinolysis during normal pregnancy and severe preeclampsia relationships between plasma levels of plasminogen activators and inhibitors.
Nakashima A; Kobayashi T; Terao T
Gynecol Obstet Invest; 1996; 42(2):95-101. PubMed ID: 8878712
[TBL] [Abstract][Full Text] [Related]
6. The imbalance of plasminogen activators and inhibitor in preeclampsia.
Gao M; Nakabayashi M; Sakura M; Takeda Y
J Obstet Gynaecol Res; 1996 Feb; 22(1):9-16. PubMed ID: 8624901
[TBL] [Abstract][Full Text] [Related]
7. Involvement of fibrinolytic factors in mid trimester amniotic fluid with development of severe early-onset preeclampsia.
Adachi T; Nakabayashi M; Sakura M; Ando K
Semin Thromb Hemost; 1999; 25(5):447-50. PubMed ID: 10625200
[TBL] [Abstract][Full Text] [Related]
8. Imbalance of plasminogen activator inhibitor-I/ tissue plasminogen activator and tissue factor/tissue factor pathway inhibitor in young Japanese men with myocardial infarction.
Saigo M; Abe S; Ogawa M; Yamashita T; Biro S; Minagoe S; Maruyama I; Tei C
Thromb Haemost; 2001 Nov; 86(5):1197-203. PubMed ID: 11816707
[TBL] [Abstract][Full Text] [Related]
9. Increased plasminogen activator inhibitor-1, decreased tissue factor pathway inhibitor, and unchanged thrombin-activatable fibrinolysis inhibitor levels in patients with primary hyperparathyroidism.
Erem C; Kocak M; Nuhoglu I; Yilmaz M; Ucuncu O
Eur J Endocrinol; 2009 May; 160(5):863-8. PubMed ID: 19233920
[TBL] [Abstract][Full Text] [Related]
10. Modulation of tissue plasminogen activator and plasminogen activator inhibitor-1 by transforming growth factor-beta in human retinal glial cells.
Schacke W; Beck KF; Pfeilschifter J; Koch F; Hattenbach LO
Invest Ophthalmol Vis Sci; 2002 Aug; 43(8):2799-805. PubMed ID: 12147618
[TBL] [Abstract][Full Text] [Related]
11. Pitavastatin alters the expression of thrombotic and fibrinolytic proteins in human vascular cells.
Markle RA; Han J; Summers BD; Yokoyama T; Hajjar KA; Hajjar DP; Gotto AM; Nicholson AC
J Cell Biochem; 2003 Sep; 90(1):23-32. PubMed ID: 12938153
[TBL] [Abstract][Full Text] [Related]
12. Effects of a low molecular weight heparin, bemiparin, and unfractionated heparin on hemostatic properties of endothelium.
Pérez-Ruiz A; Montes R; Carrasco P; Rocha E
Clin Appl Thromb Hemost; 2002 Jan; 8(1):65-71. PubMed ID: 11991242
[TBL] [Abstract][Full Text] [Related]
13. Norethisterone acetate alters coagulation gene expression in vitro in human cell culture.
Brosnan JF; Sheppard BL; Kelly LA; O'Leary JJ; Norris LA
Thromb Res; 2013 Jan; 131(1):72-7. PubMed ID: 22999413
[TBL] [Abstract][Full Text] [Related]
14. Blood coagulation and fibrinolysis in patients with acromegaly: increased plasminogen activator inhibitor-1 (PAI-1), decreased tissue factor pathway inhibitor (TFPI), and an inverse correlation between growth hormone and TFPI.
Erem C; Nuhoglu I; Kocak M; Yilmaz M; Sipahi ST; Ucuncu O; Ersoz HO
Endocrine; 2008 Jun; 33(3):270-6. PubMed ID: 19016004
[TBL] [Abstract][Full Text] [Related]
15. Role of hypoxia-inducible transcription factors 1alpha and 2alpha in the regulation of plasminogen activator inhibitor-1 expression in a human trophoblast cell line.
Meade ES; Ma YY; Guller S
Placenta; 2007 Oct; 28(10):1012-9. PubMed ID: 17570486
[TBL] [Abstract][Full Text] [Related]
16. Effect of Tisseel on expression of tissue plasminogen activator and plasminogen activator inhibitor-1.
Diamond MP; Kruger M; Saed GM
Fertil Steril; 2004 Jun; 81(6):1657-64. PubMed ID: 15193491
[TBL] [Abstract][Full Text] [Related]
17. Loss of Thrombomodulin in Placental Dysfunction in Preeclampsia.
Turner RJ; Bloemenkamp KW; Bruijn JA; Baelde HJ
Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):728-35. PubMed ID: 26891741
[TBL] [Abstract][Full Text] [Related]
18. Imbalance of plasminogen activator inhibitor type-1 (PAI-1) and tissue plasminogen activator (t-PA) activity in patients with Noonan syndrome.
Mehta P; Parker RI
J Pediatr Hematol Oncol; 2010 Oct; 32(7):532-6. PubMed ID: 20686427
[TBL] [Abstract][Full Text] [Related]
19. The role of tissue factor in patients undergoing open repair of ruptured and nonruptured abdominal aortic aneurysms.
Hobbs SD; Haggart P; Fegan C; Bradbury AW; Adam DJ
J Vasc Surg; 2007 Oct; 46(4):682-6. PubMed ID: 17764874
[TBL] [Abstract][Full Text] [Related]
20. Calcitriol downregulates TNF-α and IL-6 expression in cultured placental cells from preeclamptic women.
Noyola-Martínez N; Díaz L; Avila E; Halhali A; Larrea F; Barrera D
Cytokine; 2013 Jan; 61(1):245-50. PubMed ID: 23103122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
